Parkside Financial Bank & Trust Acquires 282 Shares of Metlife Inc (NYSE:MET)

Parkside Financial Bank & Trust increased its position in shares of Metlife Inc (NYSE:MET) by 14.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,198 shares of the financial services provider’s stock after acquiring an additional 282 shares during the period. Parkside Financial Bank & Trust’s holdings in Metlife were worth $104,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the business. Private Trust Co. NA raised its holdings in Metlife by 4.8% in the 2nd quarter. Private Trust Co. NA now owns 7,305 shares of the financial services provider’s stock worth $362,000 after purchasing an additional 337 shares in the last quarter. Rockland Trust Co. raised its stake in Metlife by 5.3% during the 2nd quarter. Rockland Trust Co. now owns 6,679 shares of the financial services provider’s stock worth $332,000 after acquiring an additional 339 shares during the period. DNB Asset Management AS boosted its stake in Metlife by 24.9% during the second quarter. DNB Asset Management AS now owns 188,012 shares of the financial services provider’s stock worth $9,339,000 after buying an additional 37,463 shares during the period. WINTON GROUP Ltd purchased a new stake in shares of Metlife during the second quarter valued at $13,179,000. Finally, Burns J W & Co. Inc. NY raised its holdings in shares of Metlife by 3.2% in the second quarter. Burns J W & Co. Inc. NY now owns 24,553 shares of the financial services provider’s stock valued at $1,220,000 after acquiring an additional 756 shares in the last quarter. 75.59% of the stock is owned by institutional investors and hedge funds.

Shares of NYSE MET traded down $0.08 during trading on Monday, reaching $49.24. 150,988 shares of the company traded hands, compared to its average volume of 5,417,675. The company has a quick ratio of 0.14, a current ratio of 0.15 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $45.78 billion, a PE ratio of 9.14, a P/E/G ratio of 1.09 and a beta of 1.12. The firm has a 50 day simple moving average of $46.53 and a 200-day simple moving average of $47.39. Metlife Inc has a 52-week low of $37.76 and a 52-week high of $51.16.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.27 earnings per share for the quarter, missing the consensus estimate of $1.40 by ($0.13). Metlife had a net margin of 10.82% and a return on equity of 8.82%. The firm had revenue of $16.92 billion during the quarter, compared to the consensus estimate of $16.37 billion. During the same quarter in the previous year, the firm earned $1.38 earnings per share. The business’s revenue was up 3.2% compared to the same quarter last year. As a group, research analysts predict that Metlife Inc will post 5.55 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Tuesday, November 5th will be issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.57%. The ex-dividend date is Monday, November 4th. Metlife’s payout ratio is currently 32.65%.

Several research firms have recently issued reports on MET. Citigroup cut their price objective on shares of Metlife from $42.00 to $41.00 and set a “sell” rating on the stock in a report on Friday, September 13th. Zacks Investment Research downgraded Metlife from a “hold” rating to a “sell” rating and set a $51.00 price objective for the company. in a research note on Wednesday, November 6th. B. Riley reiterated a “neutral” rating on shares of Metlife in a report on Tuesday, October 15th. Morgan Stanley decreased their price objective on Metlife from $54.00 to $53.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 20th. Finally, UBS Group lifted their target price on Metlife from $46.00 to $47.00 and gave the company a “neutral” rating in a research note on Thursday, October 10th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $49.51.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: What are the advantages to having securities held in street name?

Want to see what other hedge funds are holding MET? Visit to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with's FREE daily email newsletter.